The Long-Term Outcome of Boys With Partial Androgen Insensitivity Syndrome and a Mutation in the Androgen Receptor Gene

Autor: Lucas-Herald, A., Bertelloni, S., Juul, A., Bryce, J., Jiang, J., Rodie, M., Sinnott, R., Boroujerdi, M., Lindhardt Johansen, M., Hiort, O., Holterhus, P. M., Cools, Martine, Guaragna-Filho, G., Guerra-Junior, G., Weintrob, N., Hannema, S., Drop, S., Guran, T., Darendeliler, F., Nordenstrom, A., Hughes, I. A., Acerini, C., Tadokoro-Cuccaro, R., Ahmed, S. F.
Přispěvatelé: Pediatric surgery
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Zdroj: Lucas-Herald, A, Bertelloni, S, Juul, A, Bryce, J, Jiang, J, Rodie, M, Sinnott, R, Boroujerdi, M, Lindhardt Johansen, M, Hiort, O, Holterhus, P M, Cools, M, Guaragna-Filho, G, Guerra-Junior, G, Weintrob, N, Hannema, S, Drop, S, Guran, T, Darendeliler, F, Nordenstrom, A, Hughes, I A, Acerini, C, Tadokoro-Cuccaro, R & Ahmed, S F 2016, ' The long-term outcome of boys with partial androgen insensitivity syndrome and a mutation in the androgen receptor gene ', Journal of Clinical Endocrinology and Metabolism, vol. 101, no. 11, pp. 3959-3967 . https://doi.org/10.1210/jc.2016-1372
The Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 101(11), 3959-3967. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 101(11), 3959-3967
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
ISSN: 0021-972X
3959-3967
1945-7197
DOI: 10.1210/jc.2016-1372
Popis: Background: In boys with suspected partial androgen insensitivity syndrome (PAIS), systematic evidence that supports the long-term prognostic value of identifying a mutation in the androgen receptor gene (AR) is lacking. Objective: To assess the clinical characteristics and long-term outcomes in young men with suspected PAIS in relation to the results of AR analysis. Methods: Through the International Disorders of Sex Development Registry, clinical information was gathered on young men suspected of having PAIS (n = 52) who presented before the age of 16 years and had genetic analysis of AR. Results: The median ages at presentation and at the time of the study were 1 month (range, 1 day to 16 years) and 22 years (range, 16 to 52 years), respectively. Of the cohort, 29 men (56%) had 20 different AR mutations reported. At diagnosis, the median external masculinization scores were 7 and 6 in cases with and without AR mutation, respectively (P = .9), and median current external masculinization scores were 9 and 10, respectively (P = .28). Thirty-five men (67%) required at least one surgical procedure, and those with a mutation were more likely to require multiple surgeries for hypospadias (P = .004). All cases with an AR mutation had gynecomastia, compared to 9% of those without an AR mutation. Of the six men who had a mastectomy, five (83%) had an AR mutation. Conclusions: Boys with genetically confirmed PAIS are likely to have a poorer clinical outcome than those with XY DSD, with normal T synthesis, and without an identifiable AR mutation. Routine genetic analysis of AR to confirm PAIS informs long-term prognosis and management.
Using the I-DSD Registry, a study of long-term outcome in young men suspected of having PAIS in childhood reveals that outcome is clearly worse in those with a confirmed AR gene mutation.
Databáze: OpenAIRE